The NA03 Neuropathy Assessment Kit offers a complete solution for evaluating diabetic peripheral neuropathy. It includes essential tools to assess vibration, thermal, and tactile sensations. Designed for clinical accuracy and ease of use, this compact kit enables early diagnosis and effective management of nerve damage in diabetic patients, improving long-term foot health and preventing complications. The kit contains a miniature electronic 125Hz tuning fork Vibratip for vibration sense, one Tiptherm for thermal sense and 25 nos of 10gm Monofilaments.

The Vibroscreen Digital Biothesiometer is designed for conducting a large medical camp and a reliable tool for assessing vibration perception thresholds in patients at risk of neuropathy. Its simple operation is ideal for screening a large patient group in a shorter duration. This device supports timely diagnosis and intervention, helping clinicians monitor progression and prevent foot complications associated with diabetic neuropathy.

Vibrotest Lx is a precision digital Biothesiometer designed to detect vibration perception loss in diabetic patients. Its ergonomic design and user-friendly controls make it suitable for clinics and hospitals. By measuring sensory response accurately, Vibrotest Lx aids in the early diagnosis of peripheral neuropathy and supports proactive patient care and foot protection strategies. This popular model is computer enabled and connects with any Windows-operated computer for storage and patient report generation.

The Vibrometer offers digital accuracy in measuring vibration sensitivity, making it essential for diagnosing diabetic neuropathy in medical colleges and research institutes. With its calibrated output and smooth operation, it ensures consistency across multiple assessments. Compact and efficient, the Vibrometer helps clinicians identify early signs of nerve damage and take timely preventive measures to avoid complications like foot ulcers. This model is computer and mobile enabled and connects with any Windows-operated computer or Android mobiles for storage and patient report generation. The software helps to test for Erectile Dysfunction and also allow the user to create their own testing protocol.

The Vibrodop combines vibration threshold testing with Doppler-based vascular screening in one advanced device. It enables clinicians to assess both neuropathy and peripheral arterial disease simultaneously. With digital precision and dual functionality, Vibrodop enhances clinical efficiency, allowing early detection of diabetic foot risks and supporting comprehensive foot care protocols in one streamlined solution. This device is also computer enabled for data storage and patient report generation. This device is also computer enabled for data storage and patient report generation.

Thermometry HCP is a specialized device for measuring foot temperature variations, an early indicator of inflammation or ulcer risk in diabetic patients. It provides fast, non-invasive readings with high sensitivity. Ideal for routine foot screening, this tool supports preventative care by detecting subtle changes in skin temperature before visible symptoms appear.

The Vibrotherm Dx is a dual-modality neuropathy analyser that combines vibration perception threshold and thermal perception threshold testing. Designed for advanced diabetic foot screening, it offers comprehensive, real-time analysis of sensory loss. The device’s compact design and user-friendly interface make it ideal for use in clinical settings aiming for early and accurate neuropathy diagnosis. This device is also computer enabled for data storage and patient report generation.

The CANS504 is a sophisticated analyser for evaluating cardiac autonomic neuropathy (CAN), a serious complication in diabetes. It measures heart rate variability and blood pressure measurement in different postures and evaluates the autonomic function using standardized EWING protocols. With non-invasive testing and detailed reports, this system helps clinicians detect early signs of CAN, guiding timely interventions and improving cardiovascular risk management in diabetic patients.